| ADAM9 | Disintegrin and metalloproteinase domain-containing protein 9 |
| Ago2 | Agonaute2 protein |
| Akt | Protein kinase B |
| ALF | Acute liver failure |
| ALP | Alkaline phosphatase |
| AML12 | Alpha mouse liver 12 |
| BAK1 | Bcl-2 antagonist killer 1 |
| BMSCs | Bone marrow stromal cells |
| CABLES1 | Cdk5 and Abl enzyme substrate 1 |
| CCR7 | C-C chemokine receptor type 7 |
| CC | C-C motif |
| CCL2 | Targeting chemokine (C-C motif) ligand 2 |
| CLP | Cecal ligation and puncture |
| CO | Carbon monoxide |
| CRC | Colorectal cancer |
| CX3CL1 | Fractalkine |
| DCs | Dendritic cells |
| DRP1 | Dynamin-related protein 1 |
| EAE | Experimental autoimmune encephalomyelitis |
| ECC-1 | Human endometrial cancer cells |
| FACS | Fluorescence-activated cell sorting |
| Gal-1 | Galectin-1 |
| Gal-9 | Galectin-9 |
| GvHD | Graft-versus-Host-Disease |
| hFOB | Human fetal osteoblastic cell line |
| HGF-1 | Hepatocyte growth factor - 1 |
| HMGB1 | High Mobility Group-B1 |
| hnRNP | Heterogeneous nuclear ribonucleoproteins |
| HO-1 | Heme oxygenase-1 |
| IDO | Indoleamine 2 3-dioxygenase |
| IL-1 | Interleukin-1 |
| IL-10 | Interleukin-10 |
| IL-1Ra | Interleukin 1 receptor antagonist |
| ILVs | Interluminal vesicles |
| IRAK1 | IL-1 receptor-associated kinase 1 |
| IRI | Renal ischemia injury |
| ISCT | International Society for Cellular Therapy |
| ISK | Ishikawa |
| ITGA2 | Integrin alpha-2 |
| JAK-STAT | Janus kinase/signal transducers and activators of transcription |
| LIF | Leukemia inhibitory factor |
| LKB1 | Liver kinase B1 |
| MAPK | Mitogen-activated protein kinase |
| Mecp2 | Methyl CpG binding protein |
| MISEV | Minimal information for studies of extracellular vesicles guidelines |
| mpCCL2 | Metalloproteinase-processed-C motif chemokine ligand2 |
| MSCs | Mesenchymal stem cells |
| MSC-EVs | MSC-derived extracellular vesicles |
| MVBs | Multivesicular bodies |
| MVs | Microvesicles |
| ncRNAs | Non-coding RNAs |
| NEUROD1 | Neurogenic differentiation 1 |
| NK | Natural killer |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLRP3 | Nacht, LRR and PYD domains—containing protein3 |
| NO | Nitric oxide |
| NOS | Nitric oxide synthase |
| OCN | Osteocalcin |
| OPN | Osteopontin |
| PBMCs | Peripheral Blood Mononuclear Cells |
| PGE2 | Prostaglandin E2 |
| PI3K | Phosphatidylinositol 3-kinase |
| pri-miRNAs | Primary miRNAs |
| RB1 | Retinoblastoma-associated protein |
| RISC | RNA-induced silencing complex |
| Runx2 | Runt-related transcript factor-2 |
| Sema3A | Semaphorin-3A |
| SOCS3 | Suppressor of cytokine signaling 3 |
| STAT3 | Signal transducer and activator of transcription 3 |
| SYNCRIP | Synaptotagmin-binding cytoplasmic RNA-interacting protein |
| TEMs | Tetraspanin-enriched microdomains |
| TGF-β | Tumor growth factor β |
| Th1 | T-helper 1 cell |
| Th17 | T-helper 17 cell |
| TIM-3 | T cell immunoglobulin domain and mucin domain-3 |
| Treg | Regulatory T cell |
| TRAF6 | TNF receptor-associated factor 6 |
| Tsc1 | Tuberous sclerosis 1 |
| TSG6 | Tumor necrosis factor-inducible gene 6 protein |
| VEGF | Vascular endothelial growth factor |
| XPO5 | Exportin-5 |